trending Market Intelligence /marketintelligence/en/news-insights/trending/-aDvpzK50ceMDk4DMjDeGg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Odonate Therapeutics appoints director

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Odonate Therapeutics appoints director

Odonate Therapeutics Inc. appointed Laura Douglass to its board, effective Dec. 3.

Douglass is the president and CEO of Next Generation Clinical Research Consulting Inc., a contract research organization in the pharmaceutical industry.

Odonate Therapeutics is a pharmaceutical company developing treatments for cancer.